<code id='71EA49BFB1'></code><style id='71EA49BFB1'></style>
    • <acronym id='71EA49BFB1'></acronym>
      <center id='71EA49BFB1'><center id='71EA49BFB1'><tfoot id='71EA49BFB1'></tfoot></center><abbr id='71EA49BFB1'><dir id='71EA49BFB1'><tfoot id='71EA49BFB1'></tfoot><noframes id='71EA49BFB1'>

    • <optgroup id='71EA49BFB1'><strike id='71EA49BFB1'><sup id='71EA49BFB1'></sup></strike><code id='71EA49BFB1'></code></optgroup>
        1. <b id='71EA49BFB1'><label id='71EA49BFB1'><select id='71EA49BFB1'><dt id='71EA49BFB1'><span id='71EA49BFB1'></span></dt></select></label></b><u id='71EA49BFB1'></u>
          <i id='71EA49BFB1'><strike id='71EA49BFB1'><tt id='71EA49BFB1'><pre id='71EA49BFB1'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:7199
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Virtual repurposing can help discover new uses for existing drugs
          Virtual repurposing can help discover new uses for existing drugs

          AdobeTheprocessfordiscoveringdrugstendstobebasedonthesamekindofpigeonholingthatdoctorsusetotreatdise

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Truvian presents data for its desktop blood

          TruvianHealthemployeewithaplateholdingreagentsusedtomeasurecommonlytestedbloodmarkers.TruvianSANDIEG